Shay Capital’s Cellebrite CLBT Stock Holding History

Shay Capital’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$324K	Hold	23,500	–	–	0.03%	331
2025 Q4	$424K	Sell	23,500 -156,200	-87%	-$2.8M	0.04%	310
2025 Q3	$3.33M	Buy	+179,700	New	+$2.82M	0.29%	75

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Shay Capital's CLBT Position: Q1 2026 in Review

Shay Capital sold out of Cellebrite (CLBT) in Q1 2026, closing a stake of 59,805 shares — an estimated $901K sold.

Shay Capital first reported a position in CLBT in Q3 2025 and held it in 2 quarters. The position peaked at $1.08M in Q4 2025. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

Shay Capital reported no remaining Cellebrite position as of Q1 2026 after selling out during the quarter.
Shay Capital sold 59,805 Cellebrite shares in Q1 2026, an estimated $901K.
Shay Capital first reported a position in Cellebrite in Q3 2025 and held it in 2 quarters.
Shay Capital's Cellebrite position peaked at $1.08M in Q4 2025.
220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Shay Capital's 13F filing for Q1 2026, filed 15 May 2026.